previous compound ID: 600 next compound
InChIKey: FLOSMHQXBMRNHR-UHFFFAOYSA-N
SMILES: CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "JW Hanrahan" "J Liao" "SD Macknight" "E Matthes" "J Goepp" "D Rotin" "DY Thomas" "B Kus" "GW Carlile"

chemical graph of compound 600





CID is 4100
synonyms found at PubChem are:
methazolamide, 554-57-4, Methenamide, Neptazane, Neptazaneat, Metazolamida, Metazolamide, Methazolamidum, Naptazane, Metazolamide [DCIT], Metazolamida [INN-Spanish], Methazolamidum [INN-Latin], UNII-W733B0S9SD, C5H8N4O3S2, CHEBI:6822, HSDB 3269, EINECS 209-066-7, N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide, BRN 0232387, UNII-DA43GW06P1, MLS000028532, CHEMBL288100, DA43GW06P1, W733B0S9SD, Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-, NCGC00016508-01, CAS-554-57-4, SMR000058287, 2-Acetylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide, 5-Acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide, N-(4-Methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)acetamide, N-(3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene)acetamide, Acetamide, N-(4-methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)-, N-[(2E)-5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide, SR-05000001844, Methazolamid, Methazolamide [INN:BAN:JAN], 2-Acetylimino-3-methyl-.delta.(4)-1,3,4-thiadiazoline-5-sulfonamide, 3-methyl-2-(2-oxo-1-azapropylidene)-1,3,4-thiadiazoline-5-sulfonamide, 5-Acetylimino-4-methyl-.delta.(2)-1,3,4-thiadiazoline-2-sulfonamide, N-(4-Methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)acetamide, N-(5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide #, Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)-, Neptazane (TN), Methazolamide,(S), Methazolamide [USP:INN:BAN:JAN], Methazolamide, MZA, Prestwick_1007, Methazolamide (MZA), Methazolamide, (Z)-, Spectrum_001615, Opera_ID_717, AC1L1HEV, CHEMBL19, MZA3, Prestwick0_000802, Prestwick1_000802, Prestwick2_000802, Prestwick3_000802, Spectrum2_001543, Spectrum3_001914, Spectrum4_000190, Spectrum5_001006, DSSTox_CID_3281, D0C2II, cid_4100, DSSTox_RID_76956, DSSTox_GSID_23281, Oprea1_161738, SCHEMBL24686, SCHEMBL24687, BSPBio_000663, BSPBio_003508, KBioGR_000739, KBioSS_002095, 4-27-00-08221 (Beilstein Handbook Reference), MLS001146905, DivK1c_000582, SPECTRUM1503252, SPBio_001386, SPBio_002584, AC1Q40D8, AC1Q40D9, BPBio1_000731, GTPL6828, Methazolamide (JAN/USP/INN), CHEMBL1335656, DTXSID1023281, SCHEMBL13825893, BDBM10881, CHEBI:94513, CTK8G0825, HMS501N04, KBio1_000582, KBio2_002095, KBio2_004663, KBio2_007231, KBio3_003013, FLOSMHQXBMRNHR-DAXSKMNVSA-N, FLOSMHQXBMRNHR-QPJJXVBHSA-N, FLOSMHQXBMRNHR-UHFFFAOYSA-N, Methazolamide, >=98% (HPLC), MolPort-001-791-152, MolPort-019-998-640, NINDS_000582, HMS1570B05, HMS1922M19, HMS2093A05, HMS2097B05, HMS2234L03, HMS3259H05, HMS3372G12, HMS3652E21, HMS3714B05, Pharmakon1600-01503252, EBD27355, HY-B0553, KS-000010PT, Tox21_110464, BDBM50013792, CCG-39321, NSC758426, SBB037875, ZINC12503151, AKOS015897587, AKOS024464790, AKOS026749792, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide, ZINC100019188, ZINC253917094, CS-2658, DB00703, FCH4114988, KS-5328, MCULE-1665001985, NC00618, NSC-758426, IDI1_000582, Methazolamide (oral, sustained release), NCGC00018188-01, NCGC00018188-02, NCGC00018188-03, NCGC00018188-04, NCGC00018188-05, NCGC00018188-06, NCGC00018188-07, NCGC00022950-03, NCGC00022950-04, NCGC00178022-01, NCGC00178022-02, AN-45878, AS-13272, CC-30264, CPD001453721, CPD001496938, H773, LS-10006, SAM002548986, SAM002589943, ST081366, SBI-0051804.P002, AB0013250, A4364, AB00490015, FT-0603467, S4039, C07764, D00655, K-9905, AB00052336_04, 554M574, A830656, L584601, Methazolamide, VETRANAL(TM), analytical standard, I09-1225, L 584601, SR-05000001844-1, SR-05000001844-2, SR-05000001844-3, BRD-K13356952-001-15-2, BRD-K71053238-001-03-6, BRD-K71053238-001-04-4, (E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene, N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide, Methazolamide, United States Pharmacopeia (USP) Reference Standard, (E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide, 5-Acetylimino-4-methyl-| currency2-1,3,4-thiadiazoline-2-sulfonamide, Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, (N(Z))-, N-(4-Methyl-2-sulfamoyl-| currency2-1,3,4-thiadiazolin-5-ylidene) acetamide, N-(4-Methyl-2-sulfamoyl-| currency2-1,3,4-thiadiazolin-5-ylidene)acetamide, N-[(2Z)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide, 1164547-86-7